Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA, No. 20-1723 (Fed. Cir. Sept. 3, 2020)

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit

AMARIN PHARMA, INC., AMARIN

PHARMACEUTICALS IRELAND LIMITED,

Plaintiffs-Appellants

v.

HIKMA PHARMACEUTICALS USA INC., HIKMA PHARMACEUTICALS INTERNATIONAL LIMITED, DR. REDDY'S LABORATORIES, INC., DR. REDDY'S

LABORATORIES, LTD.,

Defendants-Appellees

2020-1723, 2020-1901

Appeals from the United States District Court for the District of Nevada in No. 2:16-cv-02525-MMD-NJK, Judge Miranda M. Du.

JUDGMENT

JONATHAN ELLIOT SINGER, Fish & Richardson, PC, San Diego, CA, argued for plaintiffs-appellants. Also represented by OLIVER RICHARDS; DEANNA JEAN REICHEL, Minneapolis, MN; NITIKA GUPTA FIORELLA, Wilmington, DE; JEFFREY B. ELIKAN, CHRISTOPHER NEIL SIPES, ERIC RITLAND SONNENSCHEIN, Covington & Burling LLP,

2Washington, DC. CHARLES B. KLEIN, Winston & Strawn LLP, Washington, DC, argued for all defendants-appellees. Defendants-appellees Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals International Limited also represented by CLAIRE A. FUNDAKOWSKI; ALISON MICHELLE HEYDORN, Chicago, IL; EIMERIC REIG-PLESSIS, San Francisco, CA. CONSTANCE HUTTNER, Windels Marx Lane & Mittendorf LLP, Madison, NJ, for defendants-appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. Also represented by BETH C. FINKELSTEIN, CAROLINE SUN, JAMES BARABAS.

ASHLEY CHARLES PARRISH, King & Spalding LLP, Washington, DC, for amicus curiae Aimed Alliance. Also represented by PAUL ALESSIO MEZZINA, JESSE SNYDER. RACHEL J. ELSBY, Akin Gump Strauss Hauer & Feld LLP, Washington, DC, for amicus curiae Biotechnology Innovation Organization. Also represented by JASON WEIL, Philadelphia, PA; MELISSA A. BRAND, HANSJORG SAUER, Biotechnology Innovation Organization, Washington, DC.

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: